GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth

Creates world’s first R&D Open Lab to increase understanding of non-      communicable diseases and support development of new medicines for Africa Significantly increases African manufacturing presence to build  capacity and enhance regional self sufficiency Establishes 25 academic Chairs at African universities to support development of local skills and capabilities in science, engineering, public health and other related areas Commits to train …